In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae

被引:13
作者
Lass-Flörl, C
Nagl, M
Gunsilius, E
Speth, C
Ulmer, H
Würzner, R
机构
[1] Univ Innsbruck, Inst Hyg & Sozialmed, Dept Hyg & Social Med, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Biostat & Documentat, A-6020 Innsbruck, Austria
[3] Univ Innsbruck Hosp, Dept Internal Med, Div Haematol, Innsbruck, Austria
关键词
Aspergillus; susceptibility assay; amphotericin B; liposomal formulation; colloidal dispersion;
D O I
10.1046/j.1439-0507.2002.00748.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The minimum inhibitory concentrations (MICs) of amphotericin B and lipid-based amphotericin B formulations against isolates of Aspergillus spp. were tested using a broth microdilution method. Twelve isolates of Aspergillus fumigatus , eight of Aspergillus flavus , six of Aspergillus niger and seven of Aspergillus terreus were examined. In addition, an assay for hyphae of Aspergillus spp. was performed since the invasive form is manifested by the appearance of hyphal structures. MICs of hyphae against lipid-based amphotericin B formulations were within three dilutions higher than those against conidia for almost all isolates of Aspergillus spp. (P < 0.01). In contrast, the differences in the in vitro efficacies of amphotericin B were the lowest for Aspergillus spp. This study demonstrates the importance of the type of inoculum used to test antifungal susceptibilities of Aspergillus spp. The significance of these results for in vivo outcome needs to be determined.
引用
收藏
页码:166 / 169
页数:4
相关论文
共 18 条
  • [1] COMPARISON OF THE INVITRO ANTIFUNGAL ACTIVITY OF FREE AND LIPOSOME-ENCAPSULATED AMPHOTERICIN-B
    ANAISSIE, E
    PAETZNICK, V
    PROFFITT, R
    ADLERMOORE, J
    BODEY, GP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (08) : 665 - 668
  • [2] BEYER J, 1994, ANTIMICROB AGENTS CH, V38, P314
  • [3] DENNING DW, 1991, J ANTIMICROB CHEMOTH, V28, P1, DOI 10.1093/jac/28.suppl_B.1
  • [4] PULMONARY ASPERGILLOSIS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    DENNING, DW
    FOLLANSBEE, SE
    SCOLARO, M
    NORRIS, S
    EDELSTEIN, H
    STEVENS, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (10) : 654 - 662
  • [5] Invasive aspergillosis
    Denning, DW
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 781 - 803
  • [6] COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI
    ESPINELINGROFF, A
    DAWSON, K
    PFALLER, M
    ANAISSIE, E
    BRESLIN, B
    DIXON, D
    FOTHERGILL, A
    PAETZNICK, V
    PETER, J
    RINALDI, M
    WALSH, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 314 - 319
  • [7] PROLONGED GRANULOCYTOPENIA - THE MAJOR RISK FACTOR FOR INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH ACUTE-LEUKEMIA
    GERSON, SL
    TALBOT, GH
    HURWITZ, S
    STROM, BL
    LUSK, EJ
    CASSILETH, PA
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (03) : 345 - 351
  • [8] In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
    Johnson, EM
    Szekely, A
    Warnock, DW
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) : 741 - 745
  • [9] In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis
    Lass-Flörl, C
    Kofler, G
    Kropshofer, G
    Hermans, J
    Kreczy, A
    Dierich, MP
    Niederwieser, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 497 - 502
  • [10] Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining
    Lass-Flörl, C
    Nagl, M
    Speth, C
    Ulmer, H
    Dierich, MP
    Würzner, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 124 - 128